Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
Europe
0
Canada
0
Australia
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2-diethylaminopropiophenone
2. Amfepramon
3. Amfepramone
4. Anorex
5. Delgamer
6. Diethylpropion
7. Dietil Retard
8. Dietil-retard
9. Dietilretard
10. Hydrochloride, Diethylpropion
11. Ifa Norex
12. Lipomin
13. Maruate
14. Modratan
15. Neobes
16. Nobesine
17. Norex, Ifa
18. Phepranon
19. Prfamone
20. Propion
21. Regenon
22. Regibon
23. Tenuate
24. Tepanil
1. Amfepramone Hydrochloride
2. 134-80-5
3. Moderatan
4. Dobesin
5. Tenuate
6. Diethylpropion Hcl
7. Tepanil
8. Anorex
9. Tenuate Dospan
10. Regenon Hydrochloride
11. 2-(diethylamino)propiophenone Hydrochloride
12. Amfepramone (hydrochloride)
13. Prefamone
14. Regenon
15. Amphepramonum Hydrochloride
16. 1-propanone, 2-(diethylamino)-1-phenyl-, Hydrochloride
17. 19v2pl39ng
18. Diethylpropion Hydrochloride Civ
19. Alpha-benzoyltriethylammonium Chloride
20. Alpha-benzoyltriethylamine Hydrochloride
21. D03801
22. Diethylpropion Hydrochloride [usp]
23. Menutil
24. 1-phenyl-2-diethylaminopropanone-1 Hydrochloride
25. Magrex Retard
26. Tenuate-dospan
27. Amfepramon Hydrochloride
28. Lineal-rivo
29. Tepanil Ten-tab
30. Nu-dispoz
31. Dsstox_cid_27816
32. Dsstox_rid_82580
33. Dsstox_gsid_47838
34. Propiophenone, 2-(diethylamino)-, Hydrochloride
35. Diethylpropion Hydrochloride (usp)
36. 2-(diethylamino)-1-phenylpropan-1-one Hydrochloride
37. Cas-134-80-5
38. Chebi:643703
39. 2-diethylaminopropiophenone Hydrochloride
40. Sr-01000220674
41. Ncgc00167475-01
42. Einecs 205-156-5
43. Unii-19v2pl39ng
44. Tenuate (tn)
45. Rac Diethylpropion-d10 Hydrochloride
46. Diethylproion Hydrochloride
47. Cambridge Id 5809497
48. Chembl1693
49. Schembl15483
50. 2-(diethylamino)-1-phenyl-1-propanone Hydrochloride
51. 2-(diethylamino)-1-phenylpropan-1-one;hydrochloride
52. Dtxsid4047838
53. Hy-b0981
54. Tox21_112479
55. Akos015962206
56. Tox21_112479_1
57. Ccg-220122
58. Cs-4472
59. Diethylpropion Hydrochloride [mi]
60. Ncgc00167475-02
61. Ac-16025
62. Amfepramone Hydrochloride [who-dd]
63. As-16865
64. Diethylpropion Hydrochloride [mart.]
65. Diethylpropion Hydrochloride [vandf]
66. Diethylpropion Hydrochloride [usp-rs]
67. .alpha.-benzoyltriethylamine Hydrochloride
68. 090d846
69. Diethylpropion Hydrochloride [orange Book]
70. Diethylpropion Hydrochloride [usp Monograph]
71. Sr-01000220674-1
72. Sr-01000220674-2
73. Q27105182
74. Diethylpropion Hydrochloride Solution, 1.0 Mg/ml In Methanol (with 1% 1 M Hcl; As Free Base), Certified Reference Material
Molecular Weight | 241.76 g/mol |
---|---|
Molecular Formula | C13H20ClNO |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 5 |
Exact Mass | 241.1233420 g/mol |
Monoisotopic Mass | 241.1233420 g/mol |
Topological Polar Surface Area | 20.3 Ų |
Heavy Atom Count | 16 |
Formal Charge | 0 |
Complexity | 193 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 6 | |
---|---|
Drug Name | Diethylpropion hydrochloride |
Active Ingredient | Diethylpropion hydrochloride |
Dosage Form | Tablet, extended release; Tablet |
Route | Oral |
Strength | 75mg; 25mg |
Market Status | Prescription |
Company | Lannett Holdings; Corepharma; Avanthi |
2 of 6 | |
---|---|
Drug Name | Tenuate |
Active Ingredient | Diethylpropion hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 25mg |
Market Status | Prescription |
Company | Watson Pharms |
3 of 6 | |
---|---|
Drug Name | Tenuate dospan |
PubMed Health | Diethylpropion (By mouth) |
Drug Classes | Appetite Suppressant, Centrally Acting |
Drug Label | Diethylpropion hydrochloride, USPis available for oral administration in immediate-release tablets containing 25 mg diethylpropion hydrochloride. The inactive ingredients in each immediate-release tablet are: corn starch, lactose monohydrate, magne... |
Active Ingredient | Diethylpropion hydrochloride |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | 75mg |
Market Status | Prescription |
Company | Watson Pharms |
4 of 6 | |
---|---|
Drug Name | Diethylpropion hydrochloride |
Active Ingredient | Diethylpropion hydrochloride |
Dosage Form | Tablet, extended release; Tablet |
Route | Oral |
Strength | 75mg; 25mg |
Market Status | Prescription |
Company | Lannett Holdings; Corepharma; Avanthi |
5 of 6 | |
---|---|
Drug Name | Tenuate |
Active Ingredient | Diethylpropion hydrochloride |
Dosage Form | Tablet |
Route | Oral |
Strength | 25mg |
Market Status | Prescription |
Company | Watson Pharms |
6 of 6 | |
---|---|
Drug Name | Tenuate dospan |
PubMed Health | Diethylpropion (By mouth) |
Drug Classes | Appetite Suppressant, Centrally Acting |
Drug Label | Diethylpropion hydrochloride, USPis available for oral administration in immediate-release tablets containing 25 mg diethylpropion hydrochloride. The inactive ingredients in each immediate-release tablet are: corn starch, lactose monohydrate, magne... |
Active Ingredient | Diethylpropion hydrochloride |
Dosage Form | Tablet, extended release |
Route | Oral |
Strength | 75mg |
Market Status | Prescription |
Company | Watson Pharms |
Appetite Depressants
Agents that are used to suppress appetite. (See all compounds classified as Appetite Depressants.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
66
PharmaCompass offers a list of Diethylpropion Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Diethylpropion Hydrochloride manufacturer or Diethylpropion Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diethylpropion Hydrochloride manufacturer or Diethylpropion Hydrochloride supplier.
PharmaCompass also assists you with knowing the Diethylpropion Hydrochloride API Price utilized in the formulation of products. Diethylpropion Hydrochloride API Price is not always fixed or binding as the Diethylpropion Hydrochloride Price is obtained through a variety of data sources. The Diethylpropion Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Neobes manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Neobes, including repackagers and relabelers. The FDA regulates Neobes manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Neobes API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Neobes manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Neobes supplier is an individual or a company that provides Neobes active pharmaceutical ingredient (API) or Neobes finished formulations upon request. The Neobes suppliers may include Neobes API manufacturers, exporters, distributors and traders.
click here to find a list of Neobes suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Neobes DMF (Drug Master File) is a document detailing the whole manufacturing process of Neobes active pharmaceutical ingredient (API) in detail. Different forms of Neobes DMFs exist exist since differing nations have different regulations, such as Neobes USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Neobes DMF submitted to regulatory agencies in the US is known as a USDMF. Neobes USDMF includes data on Neobes's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Neobes USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Neobes suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Neobes Drug Master File in Korea (Neobes KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Neobes. The MFDS reviews the Neobes KDMF as part of the drug registration process and uses the information provided in the Neobes KDMF to evaluate the safety and efficacy of the drug.
After submitting a Neobes KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Neobes API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Neobes suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Neobes as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Neobes API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Neobes as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Neobes and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Neobes NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Neobes suppliers with NDC on PharmaCompass.
Neobes Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Neobes GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Neobes GMP manufacturer or Neobes GMP API supplier for your needs.
A Neobes CoA (Certificate of Analysis) is a formal document that attests to Neobes's compliance with Neobes specifications and serves as a tool for batch-level quality control.
Neobes CoA mostly includes findings from lab analyses of a specific batch. For each Neobes CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Neobes may be tested according to a variety of international standards, such as European Pharmacopoeia (Neobes EP), Neobes JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Neobes USP).